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Introduction: Subdural hematoma (SDH) is a well described risk factor in the development of Status Epilepticus (SE),
however the epidemiology of SE after SDH is unknown. In this study, we sought to determine the epidemiology of SE,
the prevalence of risk factors, and impact on hospital mortality using a large administrative dataset.
Methods: Data was derived from the Nationwide Inpatient Sample from 1988 through 2011. We queried the NIS
database for patients older than 18 years, with a diagnosis of SDH and SE. Diagnoses were defined by ICD 9 CM codes
432.1, 852.2, 852.3 and 345.3 for SE. Adjusted incidence rates of admission and prevalence proportions were
calculated. Multivariate logistic models were then fitted to assess for the impact of status epilepticus on hospital
mortality.
Results: Over the 23-year period, we identified more than 1,583,255 admissions with a diagnosis of SDH. The prevalence
of SE in this cohort was 0.5% (7,421 admissions). The population adjusted incidence rate of admissions of SDH increased
from 13/100,000 in 1988 to 38/100,000 in 2011. The prevalence of SE in SDH, increased from 0.5% in 1988 to 0.7% in
2011. In hospital mortality of patients with SDH and without SE decreased from 17.9% to 10.3% while in hospital
mortality of patients with SDH and SE did not statistically change. Mortality increased over the same period (2.3/100,000
in 1988 to 3.9/100.000 in 2011) and the diagnosis of SE increased mortality in this cohort (OR 2.17, p < 0.0001). The
risk of SE remained stable throughout the study period, but was higher among older patients, blacks, and in those
with respiratory, metabolic, hematological, and renal system dysfunction.
Conclusion: Our study demonstrates that the incidence of admissions of SDH is increasing in the United States.
Despite a decline in the overall SDH related mortality, SE increased the risk of in-hospital death in patients with a
primary diagnosis of SDH.
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Subdural hematomas (SDH) are most often described as
resulting from traumatic brain injury (TBI) of varying
degrees. In survivors of TBI, post traumatic epilepsy
(PTE) is a well-known complication (Tomkins et al.
2008; Storti et al. 2012; Steg 1993; Hung and Chen
2012; Gupta and Gupta 2006; Agrawal et al. 2006), and* Correspondence: seifi@uthscsa.edu
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in any medium, provided the original work is poften complicates treatment in the hospitalized patient
(Annegers et al. 1998). The epidemiology of status epilep-
ticus in patients admitted with SDH is however poorly
understood. Similarly, the pathophysiology of epilepto-
genesis in these patients is incompletely known, but is
thought to be biphasic, with 1) early and 2) late post trau-
matic epilepsy (PTE) (Agrawal et al. 2006). One hypoth-
esis states that in the immediate peri-injury period, brain
swelling, cerebral ischemia and the release of excitatory
amino acids and other toxins precipitate neuronal dam-
age (Agrawal et al. 2006; Brodersen and Gjerris 1975).
Comparatively, in the late post injury period, an excess ofOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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cytotoxic hydroxyls, reactive oxygen species moieties and
glutamate accumulation (Payan et al. 1970). These com-
pounds collectively promote neuronal damage propa-
gating the creation of an epileptogenic nidus, and
occasionally leading to status epilepticus (Willmore et al.
1978; Rubin and Willmore 1980; Shaver et al. 1996;
Sahuquillo-Barris et al. 1988; Becker 1986).
The diagnosis of status epilepticus in the setting of an
extra-axial hemorrhage in general portends a poor prog-
nosis (Dennis et al. 2002; Claassen et al. 2006; Little
et al. 2007). In patients with acute or chronic SDH the
risk of developing epileptiform activity is higher and in-
creases in those requiring surgical evacuation (Yeh et al.
2013; Englander et al. 2003). In addition to high mortal-
ity and morbidity, the diagnosis of SDH presents a sig-
nificant economic burden on healthcare systems and
over the last several decades has been correlated to in-
creases in health care costs (Frontera et al. 2011; Balser
et al. 2013). Although, surgical intervention through
trephination or craniotomy assisted evacuation has im-
proved mortality in some cohorts, seizures and the
diagnosis of status epilepticus (SE) may complicate
recovery (Annegers et al. 1998; Rubin and Rappaport 1993;
Cameron 1978; Drapkin 1991; Kotwica and Brzezinski
1991; Robinson 1984; Cole and Spatz 1961; Huang et al.
2011; Byung-Soo et al. 2008).
However, the epidemiology of status epilepticus (SE)
after SDH has not been studied despite the fact that an
association between SDH and seizures is widely demon-
strated in academic literature (Rubin and Rappaport
1993; Cole and Spatz 1961; Rabinstein et al. 2010; Sabo
et al. 1995; Ohno et al. 1993). Similarly, the risk factors
for SE in patients with SDH have not been sufficiently
characterized in previous literature (Huang et al. 2011;
Westmoreland 2001; Wiedemayer et al. 2002). The pur-
pose of this study was to determine the epidemiology of
SE in patients with SDH and to characterize the associ-
ated risk factors for SE in these patients. We also investi-
gated the impact of SE on in hospital mortality in patients
with SDH.
Materials and methods
In this retrospective study, data was obtained from the
Nationwide Inpatient Sample from 1988 through 2011.
The NIS, a database maintained as part of the Health-
care Utilization Project of the Agency for Healthcare
Quality and Research (HCUP-AHQR), is the largest all-
player inpatient database representing an approximate
stratified 20% sample of all non-federal, short-term,
general, and specialty hospitals serving adults in the United
States.
The International Classification of Disease – Clinical
Modification, 9th revision (ICD-9-CM) codes used toidentify SDH patients [ICD-9-CM codes 432.1 (non-
traumatic SDH) and codes 852.2 or 852.3 (traumatic
SDH)] as previously reviewed in the literature (Frontera
et al. 2011). These codes had a 70% sensitivity, 100% speci-
ficity, 94% positive predictive value, and 100% negative pre-
dictive value when listed as the primary or secondary
diagnoses (Frontera et al. 2011). This cohort included pa-
tients with acute, sub-acute and chronic SDH with the
aforementioned admission ICD-9-CM codes Table 1.
We included patients 18 years of age or older, with a
primary or secondary diagnosis of SDH. Patients’ age,
gender, and race (white, African-American, Asian-Pacific
Islander, American/Indian Eskimo, other; and not stated)
were obtained from the NIS database. From the cohort
of patients with SDH, those who developed SE during
their hospital admission, were identified using ICD-9-
CM code 345.3 (Claassen et al. 2007; Urtecho et al.
2013) as previously validated in the literature (Urtecho
et al. 2013). A 2013 study by Urtecho and colleagues val-
idated that the accuracy of the ICD-9-CM code for SE
was 100% when defined as a neurologist’s documenta-
tion of continuous clinical seizure activity for five mi-
nutes or longer, and/or two or more discrete seizures
without interictal return to baseline (clinical diagnosis)
and/or EEG consistent with SE per a board-certified neu-
rophysiologist’s interpretation (EEG diagnosis) (Urtecho
et al. 2013). Based on clinical diagnosis alone, the ICD-9-
CM code for SE carried a sensitivity of 82% (95% CI,
72–92%), specificity of 100%, PPV 100%, and NPV of 90%
(95% CI, 83–98%); based on EEG data alone, the ICD-9-
CM code for SE carried a sensitivity of 55% (95% CI,
42–67%), specificity of 100%, PPV of 100%, and NPV of
79% (95% CI, 69–89%) (Urtecho et al. 2013).
In-hospital complications and organ failures that might
have been related to the primary diagnosis, were identi-
fied among all patients, using the same ICD-9-CM codes
as demonstrated in previous literature (Charlson et al.
1987; Quan et al. 2005; Rincon et al. 2012). Hospitals
were divided by hospital location into: urban, sub-urban,
and rural; by type into community (non-academic), aca-
demic (university-based), and public; and according to
the Halpern criteria (Halpern et al. 2006), into small to
medium size (<300 beds), large (301-499 beds), and extra-
large (>500 beds).
National estimates were calculated according to accepted
guidelines for the accuracy of NIS-HCUP data (Cameron
1978). That is, using the provided discharge weights, ac-
counting for stratification, and clustering effects. For
trend analysis we used the provided supplemental files that
incorporate the newly calculated discharge weights using
the 1998 NIS definition for the discharge population and
available from the NIS-HCUP website (http://www.hcup-us.
ahrq.gov/db/nation/nis/nistrends.jsp). Continuous data were
presented as means and standard deviations or medians and
Table 1 The ICD-9-CM classification of study cohort
ICD9-CM code Description References
432.1, 852.2, 852.3 Subdural-hematoma (11, 17, 41, 43)
518.5, 518.82 Grand Mal Status
96.70, 96.71, 96.72
458.0, 458.8, 458.9, 796.3, 785.51, 785.59 Cardiovascular dysfunction, hypotension, shock -27
286.2, 286.6, 286.9, 287.3-5 Hematological dysfunction, disseminated intravascular coagulation, purpura
fulminans, coagulopathy, thrombocytopenia
-27
570, 572.2, 573.3 Hepatic dysfunction, acute hepatic failure, hepatic encephalopathy, hepatitis -27
584, 580, 585, 39.95 Renal dysfunction, acute renal failure, acute glomerulonephritis, renal shutdown,
hemodialysis
-27
293, 348.1, 348.3, 780.01, 780.09, 89.14 Neurological dysfunction, transient organic psychosis, anoxic brain injury,
encephalopathy, coma. altered consciousness, electroencephalography
-27
Comorbidities (Charlson et al. 1987) (13, 27, 30)
428.0-428.9 Congestive heart failure
401 Hypertension
249, 250 Diabetes mellitus
491, 492, 496 COPD
571 Chronic liver failure
585, 586 Chronic kidney disease
196, 199 Cancer
SDH, SE, co-morbidities, and acute organ dysfunctions used in this study.
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was presented as proportions and 95% confidence intervals
(CIs). Odds ratios (Schulte et al. 2008) were calculated to de-
termine independent predictors of hospital mortality.
Given the dichotomous outcome, multiple logistic regres-
sion modeling was used. All factors of interest were in-
cluded and parsimonious models were found by
systematically removing the least significant factor and re-
calculating the model. The analysis was conducted using
Structured Query Language (SQL) and the LME-4 package
(ver. 0.99) in the R programming language for statistical
computing (ver. 2.11), both available under the GNU Pub-
lic License (http://cran.r-project.org/). Pearson chi-square
test was used to determine statistical differences of corre-
sponding demographic parameters between 1988 and
2011. P-values are two sided and statistical significance was
judged when p < 0.05. Our reporting of observational data
conforms with Strengthening the Reporting of Observa-
tional Studies in Epidemiology STROBE guidelines (von
Elm et al. 2007). Based on the de-identified nature of the
database, the study was exempted from full IRB review.Results
Over the 23-year period, we identified 1,583,255 admis-
sions with a diagnosis of SDH. The prevalence of SE in
this cohort was 0.5% (7,421 admissions). More than 50%
of admitted patients self-identified as white, with a male
predominance of 59%, (Table 2). The population adjustedincidence rate of admissions of SDH increased from 13 per
100,000 in 1988 to 38 per 100,000 in 2011, with a con-
comitant increase in the prevalence of SE diagnosis in this
cohort, (Figure 1). More than half of admitted patients
were treated in private institutions, with relatively equal
geographic representation. Black patients had a statistically
significantly higher prevalence of SE that their white coun-
terparts (OR 1.71, p < 0.001), (Table 3).Demographics
There were no statistically significant difference in the age
distribution between patients admitted with diagnosed SE
compared to those who did not in this study group (SE;
65.53 ± 17.1, no SE; 69.64 ± 18.07). The gender distribution
was also similar in both the SE and non-SE cohorts,
(39.48% and 41% female distribution respectively). The ma-
jority of patients admitted were identified as white (50.67%
vs 56.13%), however among black patients there was a 50%
greater prevalence of SE (Table 2).Morbidity and mortality
Patients who presented with SE were more likely than
not to have respiratory (36.4% vs 8.5%), hematological
(10.8% vs 5.9%) or renal dysfunction (20.1% vs 6.8%),
(Table 2). Respiratory dysfunction was the strongest pre-
dictor of SE in this cohort (OR: 4.91, p <0.0001). The
prevalence of SE among patients with SDH increased
nominally, from 0.5% in 1988 to 0.7% in 2011, (Figure 2);
Table 2 Demographic characteristics of the study cohort
Variable No status epilepticus Percentage With status epilepticus Percentage
Number of SDH patients 1575834 99.50% 7421 0.5
1° SDH/2° SDH 1130031 / 445803 71.7%/ 28.3% 4337 / 3084 58.4%/ 41.6%
Age [Mean + SD] 69.64 + 18.07 65.53 + 17.1
Female/Male 646092 / 929742 41%/ 59% 2930 / 4491 39.5% / 60.5%
Race*
White 884516 56.10% 3760 50.70%
Black 127327 8.10% 1147 15.50%
Hispanic 95653 6.10% 581 7.80%
Asian 39711 2.50% 141 1.90%
Native American 6303 0.40% 59 0.80%
Other 30256 1.90% 159 2.10%
Not stated 391910 24.90% 1573 21.20%
Hospital characteristics*
Rural 111254 7% 323 4.30%
Urban private 913669 58% 4405 59.40%
Urban academic 550912 35% 2693 36.30%
Northeast 307918 19.50% 1479 19.90%
Midwest 352829 22.40% 1523 20.50%
South 586368 37.20% 2758 37.20%
West 328561 20.90% 1660 22.40%
Small to medium (<300 beds) 111096 7% 470 6.40%
Large (300–500 beds) 330295 21% 1633 22.00%
Extra-large (>500 beds) 1134285 72% 5317 71.60%
Major organ dysfunction
Respiratory 133631 8.50% 2701 36.40%
Hematological 92659 5.90% 804 10.80%
Hepatic 11188 0.70% 185 2.50%
Neurological 107472 6.80% 1492 20.10%
Metabolic 26632 1.69% 498 6.71%
Renal 137728 8.74% 1322 17.82%
Cardiovascular 55154 3.50% 555 7.48%
Outcome
In hospital mortality 210531 13.40% 1937 26.10%
SDH: Sub-Dural Hematoma/*: Some Data is missing.
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predictor of in-hospital mortality (OR 2.17, p <0.0001),
(Table 3). Over the course of study, there was a 7.6% re-
duction in the hospital mortality rate among patients with
SDH without recorded SE, from 17.9% in 1988 to 10.3% in
2011, (Figure 3). Throughout the course of study, there
was a 4.1% decrease in hospital mortality rates among
patients with both SDH and SE, from 27.8% in 1988
to 23.7% in 2011 (Figure 3). Independent predictors of
in-hospital mortality among admissions with SDH are
shown, (Table 4).Discussion
In the cohort of patients admitted with a primary diag-
nosis of SDH, our assessment demonstrates an ap-
proximate three-fold increase in the incidence rate of
admissions in the United States during the course of
study. Similarly, while the prevalence of SE among ad-
missions of SDH was low (0.5%) there was a statistically
significant increase in incidence rate of admissions of
SDH over the 23 years. Most importantly, though the
diagnosis of SE in this sub-set was an independent pre-
dictor of mortality, (OR 2.17, p < 0.001) the in hospital
Figure 1 The population adjusted rate of subdural hematoma (SDH) hospitalizations from 1988 through 2011 in the USA.
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wards over this time period but was not statistically signifi-
cant. Comparatively, patients without SE demonstrated
a statistically significant decrease in hospital mortality.
Whether there was a significant mortality difference be-
tween these two sub-groups cannot be ascertained from
current data.Table 3 Predictors of status epilepticus among patients
with subdural hematoma
95% CI 95% CI
Variable OR (Lower) (Upper) P-Value
Age (per year) 0.99 0.99 0.99 <0.0001
1° SDH vs. 2° SDH 0.73 0.65 0.83 <0.0001
Race (vs white)
Black 1.71 1.47 1.99 <0.0001
Hispanic 1.19 0.97 1.45 0.08
Asian 0.79 0.54 1.13 0.1
Native American 1.16 0.55 2.47 0.6
Other 1.04 0.72 1.5 0.8
Hospital characteristics
(vs small to medium)
Large 1.05 0.82 1.34 0.6
Extra-large 0.91 0.73 1.14 0.4
Major organ dysfunction
Hematologic dysfunction 1.35 1.12 1.62 0.001
Metabolic dysfunction 1.86 1.48 2.35 <0.0001
Renal dysfunction 1.47 1.25 1.72 <0.0001
CNS dysfunction 2.26 1.95 2.62 <0.0001
Respiratory dysfunction 4.91 4.31 5.58 <0.0001
Vs. Versus, SDH: Sub-Dural Hematoma.In 2011, a retrospective analysis of SDH diagnoses as
reported by the NIS demonstrated similar trends in ad-
missions. Frontera et al showed a 39% per capita in-
crease in hospitalization for patients with SDH (Frontera
et al. 2011). This increase in incidence has previously
been attributed to an aging population in the USA
(Frontera et al. 2011; Kudo et al. 1992; Santarius et al.
2009). However factors such as, improved diagnosis
either due to physicians’ evolving index of suspicion,
and more available computed tomography (CT) scanners
cannot be ruled out (Smith-Bindman et al. 2009; MPAC
(U.S.) 2007; Amis et al. 2007). Similarly, we demon-
strate a three-fold increase in the primary diagnosis of
SDH patients who are hospitalized in the United States,
(Figure 1) with no significant variance in the age distribu-
tion, (Figure 4).
The association between SDH and seizures and SE is re-
peatedly referenced in academic literature (Annegers et al.
1998; Rubin and Rappaport 1993; Cameron 1978; Drapkin
1991; Kotwica and Brzezinski 1991; Robinson 1984; Cole
and Spatz 1961; Huang et al. 2011; Westmoreland 2001;
Wiedemayer et al. 2002). On the contrary, large scale
epidemiological studies of SE in this cohort is scarce. In
our analyses, the prevlence of SE among SDH patients
was low (0.5%) with increasing prevalence over the
course of study. It is possible that this may reflect an
underdiagnoses in hospitalized patients either due to a
low index of suspicion based on other clinical findings or
insufficient use of EEG studies. Studies by two groups
Rubin and Rappaport (1993) and Ohno et al (1993) dem-
onstrated comparatively higher prevalence of seizures
in their single institution cohorts; 5.6% and 2.3% re-
spectively. More recently, a series of 100 patients with
diagnosed SDH suggested an 11% rate in diagnosis of
Figure 2 Prevalence of status epilepticus in admissions with subdural hematoma (SDH) from 1988 through 2011 in the USA.
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cases of SE (Huang et al. 2011). In a 2011 study, investi-
gators retrospectively identified patients admitted with
SDH who received surgical evacuation and electroen-
cephalography (EEG) analysis. While 87% of this cohort
had recorded epileptiform discharges, there were no re-
ported cases of SE (Rudzinski et al. 2011). Quantitative
improvement as diagnosed by EEG studies however
correlated positively with improved long term functional
outcome.Figure 3 Mortality rates among admissions with SDH, with and withoThere are only a few case reports documenting SE in
patients with SDH (Jones et al. 1989). The reason for
this lower prevalence of SE among patients with SDH
may be multi-factorial. Patients with trauma significant
enough to cause SDH with post traumatic SE may have
a higher mortality. We are unable to ascertain this rela-
tionship from NIS data. Additionally, for the identifica-
tion of SE in the setting of SDH there needs to be a high
clinical suspicion and in instances where patients are co-
matose secondary to significant injury, we recommendut status epilepticus from 1988 through 2011in the USA.
Table 4 Predictors of in-hospital mortality among patients
with subdural hematoma
95% CI 95% CI
Variable OR (upper) (Lower) P-Value
Status epilepticus 0.71 0.55 0.91 0.007
Primary SDH 1.06 1.03 2.95 <0.0001
Status epilepticus in 1° SDH 2.17 1.59 1.09 <0.0001
Age (per year) 1.01 1.01 1.1 <0.0001
Female (vs. male) 1.07 1.05 1.01 <0.0001
Race
Black (vs. white) 0.83 0.8 1.01 <0.0001
Hispanic(vs. white) 0.83 0.79 1.07 <0.0001
Asian(vs. white) 0.88 0.82 0.95 0.001
Native American (vs. white) 0.88 0.73 0.87 0.2
Other (vs. white) 0.93 0.86 0.87 0.08
Hospital Characteristics
Midwest (vs. Northeast) 0.91 0.87 0.88 <0.0001
South (vs. Northeast) 0.94 0.91 0.97 <0.0001
West (vs. Northeast) 0.84 0.81 0.95 <0.0001
Large (vs. small to medium) 1.18 1.11 1.16 <0.0001
Extra-large (vs. small to medium) 1.18 1.13 1.3 <0.0001
Rural (vs. academic) 1.23 1.16 1.24 <0.0001
Urban private (vs. academic) 1.13 1.1 1.24 <0.0001
Major Organ Dysfunction
Cardiovascular dysfunction 2.35 2.23 2.47 <0.0001
Hematologic dysfunction 2.13 2.04 2.23 <0.0001
Metabolic dysfunction 1.86 1.73 2.01 <0.0001
Renal dysfunction 1.68 1.62 1.75 <0.0001
Hepatic dysfunction 1.64 1.46 5.18 <0.0001
CNS dysfunction 2.03 1.95 2.11 <0.0001
Respiratory dysfunction 5.01 4.85 1.85 <0.0001
SDH: Sub-Dural Hematoma, vs.: Versus.
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Though the most recent European Society of Intensive
Care Medicine (ESICM) guidelines strongly suggest in-
corporation of EEG assessments in this patient popu-
lation (Claassen et al. 2013), low subscribership will
result in under diagnosis. The underlying theory for
epileptogenicity is hinged on the principle that acute
ischemia in addition to exposure to cytotoxic mediators
is the basis for neuronal injury and subsequent excit-
ability (Shaver et al. 1996; Sahuquillo-Barris et al. 1988;
Becker 1986). It follows that patients with an intact
pial-arachnoid layer are less likely to develop PTE and
SE (Tomkins et al. 2008). Whether patients who de-
velop SE after SDH present with more leptomeningeal
disruption than those who do not warrants further
study.Self-identified black patients were more likely to have
a diagnosis of SE in the setting of SDH than other ethnic
groups, Table 2. Asians on the other hand had a lower
risk of SE in our study group. In previous studies, it has
also been observed that the prevalence of epilepsy and
SE is generally higher in African-Americans than other
ethnic groups in the United States (Haerer et al. 1986;
Logroscino et al. 2005; DeLorenzo et al. 1995). The rea-
sons behind this finding is not well understood and war-
rants further studies.
Major organ dysfunction was correlated to the diagno-
sis of SE. Patients with a diagnosis of SDH were most
likely to have SE if they presented with respiratory, renal or
neurological dysfunctions, (Table 2). Whether or not this
observation is related to acute co-existing systemic injury
is currently unknown. It is also possible that these factors
directly and indirectly affect the cost of disposition in
addition to discharge morbidity in these patients. In 2011,
Frontera and colleagues demonstrated increased hospital
costs in patients presenting with multi-system injuries
(Frontera et al. 2011). Consequently the diagnosis and
treatment of any systemic derangement in patients with
SDH may impact functional outcome in these patients.
This is the first assessment of the morbidity and mor-
tality attendant to patients co-diagnosed with SE and
SDH from data report in the NIS database. We demon-
strate that SE in patients with a diagnosis of SDH is as-
sociated with an increased risk of mortality (OR 2.17,
p < 0.001); a finding consistent with smaller studies
(Sabo et al. 1995; Sung and Chu 1989; Claassen et al.
2003). We are unable to assess the impact or surgical
intervention in the subset of patients with surgically cor-
rectable lesions, or the severity of TBI in the subset who
presented after acute brain injury due to limitations of
the dataset. However, in a retrospective assessment of pa-
tients undergoing SDH clot evacuation, Rabinstein and
colleagues demonstrated a high incidence of epileptiform
activity characterized by EEG recordings, (25%); SE was
not reported in any case. Interestingly however, in their
study, the presence of epileptiform discharges on EEG re-
cordings were independently associated with poor post-
operative outcome, but not long term functional recovery
(Rabinstein et al. 2010). It is important to note that in pa-
tients with epileptiform activity anti-epileptic treatment
was initiated (Rabinstein et al. 2010). Future studies
assessing the impact of surgical intervention and the sever-
ity of trauma on SE should be undertaken.
From a public health standpoint, in critically ill patients
with severe TBI and SDH the diagnosis and treatment of
SE via continuous EEG monitoring has a positive mortality
benefit (Bleck 2012), and should be a fixture in the man-
agement of this patient population. The treatment of elec-
trocorticographic abnormalities with prophylactic AEDs
may also have clinical benefit in some subsets of this
Figure 4 Variance in the age distribution in subdural hematoma (SDH) hospitalizations from 1988 through 2011 in the USA.
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study, researchers demonstrated clinical efficacy in using
either leviteracetam (LVT) or phenytoin for seizure
prophylaxis in patients with acute or subacute SDH.
One salient differences between the two cohorts was in-
creased side effects historically attributable to phenytoin
usage, when compared to the cohort treated with LVT
(Radic et al. 2014). Contrastingly, Rappaport in 1993 re-
ported the absence of evidence for AED usage in patients
presenting with non-alcoholic patients with chronic SDH
(Rubin and Rappaport 1993).
Limitations of the study
This study has limitations which implicitly affects its in-
terpretation. ICD-9 codes have questionable accuracy,
since they may change over time (Frontera et al. 2011;
Claassen et al. 2007; Urtecho et al. 2013). Secondly, the
ICD-9-CM does not allow for differentiation between
acute, chronic and sub-acute SDH which have differing
risk factors, morbidity and mortality profiles. This study
is an observational study thus not as robust as prospect-
ive analyses; neither can we assume etiological or causal
relationships between variables and outcomes. Addition-
ally, the NIS is an inpatient database representing an
approximate stratified 20% sample of all non-federal,
short-term, general, and specialty hospitals serving adults
in the United States. This may not be an accurate represen-
tation of national trends in instances of under-reporting or
under-diagnosis. As highlighted in similar studies, the data
recorded in the NIS database includes both clinical and
electroencephalographic diagnoses of SE without clear
differentiation. The absence of standardization in the
diagnosis of SE, introduces observer biases that cannot becorrected for in this study (Urtecho et al. 2013). Surgical
interventions such as burr-hole craniotomies or trephin-
ation have been shown to affect morbidity after SDH
(Pahatouridis et al. 2013; Krupp and Jans 1995). These vari-
ables were not assessed in our study due to the limitations
of the dataset but may impact overall mortality/morbidity
rates. Long term outcomes secondary to the diagnosis of
SDH or SE were not assessed in this study; therefore it can
be argued that long outcomes after discharge may differ
from our reported data. The NHDS does not allow evalu-
ation of various other variables such as other comorbidi-
ties, rates of DNR orders, timing of therapeutics and time
of onset. These variables may have a confounding impact
on our data. There may be patients with prior diagnoses of
seizure disorders represented in this dataset. Since the NIS
describes comorbidities upon patient discharge it is impos-
sible to differentiate new diagnoses of seizure disorders
from pre-admission diagnoses.
Conclusions
Our study demonstrates an approximate three-fold in-
crease in the incidence of SDH during the study period
in the United States of America; however from our data
the incidence of SE among patients with SDH was rela-
tively low, (0.5%). The risk of SE among patients with
SDH increased with age, and higher in African-Americans
and in those with respiratory, hematological, or renal dys-
function. Despite a decline in the overall SDH related
mortality, SE increased the risk of in-hospital death in pa-
tients with primary SDH during the study period. In-
creased utilization of EEG studies may positively impact
in-hospital mortality through improved diagnosis in this
patient cohort.
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